{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:17:54Z","timestamp":1793812674247,"version":"4.6.1"},"reference-count":200,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","award":["RGP2\/95\/46"],"award-info":[{"award-number":["RGP2\/95\/46"]}],"id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes &amp; Diseases"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.gendis.2025.101880","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T16:55:36Z","timestamp":1760806536000},"page":"101880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Recent advances in human papillomavirus vaccines and therapeutic strategies: Combating cervical and non-cervical cancers"],"prefix":"10.1016","volume":"13","author":[{"given":"Md Rezaul","family":"Islam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2429-5491","authenticated-orcid":false,"given":"Abdur","family":"Rauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Most Nazmin","family":"Aktar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Naeem","family":"Hossain Fakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadiya Islam","family":"Trisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asraful Islam","family":"Asif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Harun","family":"Or Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0129-7497","authenticated-orcid":false,"given":"Md Ibrahim","family":"Khalil Al-Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gazi Kaifeara","family":"Thufa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhana Prodhan","family":"Emu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan A.","family":"Hemeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan A.","family":"Ogaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"Thiruvengadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1159-4521","authenticated-orcid":false,"given":"Seung-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0986-5484","authenticated-orcid":false,"given":"Muthu","family":"Thiruvengadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.gendis.2025.101880_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.gendis.2025.101880_bib2","first-page":"322","article-title":"Global burden of cervical cancer: current estimates, temporal trend and future projections based on the GLOBOCAN 2022","volume":"5","author":"Wu","year":"2025","journal-title":"J Natl Cancer Cent"},{"key":"10.1016\/j.gendis.2025.101880_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3257939","article-title":"Human papillomavirus infection and cervical cancer: epidemiology, screening, and vaccination \u2014 review of current perspectives","volume":"2019","author":"Chan","year":"2019","journal-title":"J Oncol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101880_bib4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s12967-025-06470-x","article-title":"Human papillomavirus (HPV) mediated cancers: an insightful update","volume":"23","author":"Baba","year":"2025","journal-title":"J Transl Med"},{"issue":"2 Suppl 1","key":"10.1016\/j.gendis.2025.101880_bib5","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ygyno.2007.07.067","article-title":"Human papillomavirus infection: epidemiology and pathophysiology","volume":"107","author":"Steben","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.gendis.2025.101880_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jcv.2004.12.006","article-title":"The papillomavirus life cycle","volume":"32","author":"Doorbar","year":"2005","journal-title":"J Clin Virol"},{"issue":"6","key":"10.1016\/j.gendis.2025.101880_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4143\/crt.2005.37.6.319","article-title":"The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis","volume":"37","author":"Yim","year":"2005","journal-title":"Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.gendis.2025.101880_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s13353-024-00883-y","article-title":"HPV-driven oncogenesis \u2014 much more than the E6 and E7 oncoproteins","volume":"66","author":"Janiszewska","year":"2025","journal-title":"J Appl Genet"},{"issue":"5","key":"10.1016\/j.gendis.2025.101880_bib9","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41571-022-00603-7","article-title":"HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management","volume":"19","author":"Lechner","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"issue":"16","key":"10.1016\/j.gendis.2025.101880_bib10","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.3390\/cancers15164080","article-title":"Human papillomavirus-associated oropharyngeal cancer: global epidemiology and public policy implications","volume":"15","author":"Ndon","year":"2023","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.gendis.2025.101880_bib11","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/jso.26687","article-title":"Epidemiology and incidence of HPV-related cancers of the head and neck","volume":"124","author":"Roman","year":"2021","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.gendis.2025.101880_bib12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2407-12-30","article-title":"Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review","volume":"12","author":"Hartwig","year":"2012","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.gendis.2025.101880_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100579","article-title":"Recurrent or primary metastatic cervical cancer: current and future treatments","volume":"7","author":"Gennigens","year":"2022","journal-title":"ESMO Open"},{"issue":"4","key":"10.1016\/j.gendis.2025.101880_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/cancers8040041","article-title":"HPV positive head and neck cancers: molecular pathogenesis and evolving treatment strategies","volume":"8","author":"Dok","year":"2016","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.gendis.2025.101880_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/jnci\/djad025","article-title":"Prophylactic human papillomavirus vaccination for prevention of oropharyngeal cancer in older men: is the juice worth the squeeze?","volume":"115","author":"Castle","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.gendis.2025.101880_bib16","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.3332\/ecancer.2025.1892","article-title":"Factors associated with human papillomavirus vaccine uptake before the health awareness, learning and education intervention in Korogocho informal settlements in Nairobi County, Kenya","volume":"19","author":"Ogolla","year":"2025","journal-title":"Ecancermedicalscience"},{"issue":"Suppl 5 (0 5)","key":"10.1016\/j.gendis.2025.101880_bib17","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1016\/j.vaccine.2012.04.108","article-title":"A review of clinical trials of human papillomavirus prophylactic vaccines","volume":"30","author":"Schiller","year":"2012","journal-title":"Vaccine"},{"issue":"1\u20133","key":"10.1016\/j.gendis.2025.101880_bib18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12026-009-8141-6","article-title":"Therapeutic HPV DNA vaccines","volume":"47","author":"Lin","year":"2010","journal-title":"Immunol Res"},{"issue":"5","key":"10.1016\/j.gendis.2025.101880_bib19","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3390\/vaccines13050524","article-title":"Past, present, and future of viral vector vaccine platforms: a comprehensive review","volume":"13","author":"Tang","year":"2025","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.gendis.2025.101880_bib20","doi-asserted-by":"crossref","DOI":"10.4081\/oncol.2012.e17","article-title":"Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection","volume":"6","author":"Senba","year":"2012","journal-title":"Oncol Rev"},{"issue":"1","key":"10.1016\/j.gendis.2025.101880_bib21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12943-025-02306-w","article-title":"Wnt signaling in cancer: from biomarkers to targeted therapies and clinical translation","volume":"24","author":"Tufail","year":"2025","journal-title":"Mol Cancer"},{"issue":"2","key":"10.1016\/j.gendis.2025.101880_bib22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0738-081X(97)00008-4","article-title":"Human papillomaviruses: general features","volume":"15","author":"Favre","year":"1997","journal-title":"Clin Dermatol"},{"issue":"2","key":"10.1016\/j.gendis.2025.101880_bib23","first-page":"F55","article-title":"Papillomavirus infections: a major cause of human cancers","volume":"1288","author":"zur Hausen","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.gendis.2025.101880_bib24","series-title":"Fields Virology","first-page":"2045","article-title":"Papillomavirinae: the viruses and their replication","author":"Howley","year":"1996"},{"issue":"2","key":"10.1016\/j.gendis.2025.101880_bib25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1128\/br.31.2.110-131.1967","article-title":"Human papova (wart) virus","volume":"31","author":"Rowson","year":"1967","journal-title":"Bacteriol Rev"},{"issue":"5","key":"10.1016\/j.gendis.2025.101880_bib26","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/ijc.21655","article-title":"Genome variation of human papillomavirus types: phylogenetic and medical implications","volume":"118","author":"Bernard","year":"2006","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.gendis.2025.101880_bib27","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jaad.2015.05.040","article-title":"Human papillomavirus vaccine trials and tribulations: clinical perspectives","volume":"73","author":"Handler","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.gendis.2025.101880_bib28","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00042560-199804010-00005","article-title":"Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors","volume":"17","author":"Palefsky","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"5","key":"10.1016\/j.gendis.2025.101880_bib29","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1529-8019.2010.01350.x","article-title":"An overview of human papillomavirus infection for the dermatologist: disease, diagnosis, management, and prevention","volume":"23","author":"Forcier","year":"2010","journal-title":"Dermatol Ther"},{"issue":"10","key":"10.1016\/j.gendis.2025.101880_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3390\/cancers8100095","article-title":"Functional roles of E6 and E7 oncoproteins in HPV-induced malignancies at diverse anatomical sites","volume":"8","author":"Tomai\u0107","year":"2016","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.gendis.2025.101880_bib31","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2886","article-title":"Human papillomavirus oncoproteins: pathways to transformation","volume":"10","author":"Moody","year":"2010","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"10.1016\/j.gendis.2025.101880_bib32","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1177\/0022034515605456","article-title":"HPV infection of the head and neck region and its stem cells","volume":"94","author":"Pullos","year":"2015","journal-title":"J Dent Res"},{"issue":"35","key":"10.1016\/j.gendis.2025.101880_bib33","doi-asserted-by":"crossref","first-page":"E7262","DOI":"10.1073\/pnas.1705622114","article-title":"Two transmembrane dimers of the bovine papillomavirus E5 oncoprotein clamp the PDGF \u03b2 receptor in an active dimeric conformation","volume":"114","author":"Karabadzhak","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"10.1016\/j.gendis.2025.101880_bib34","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virol.2013.07.008","article-title":"The E4 protein; structure, function and patterns of expression","volume":"445","author":"Doorbar","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.gendis.2025.101880_bib35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-9378-4-8","article-title":"Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline","volume":"4","author":"Schiffman","year":"2009","journal-title":"Infect Agent Cancer"},{"issue":"5","key":"10.1016\/j.gendis.2025.101880_bib36","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1590\/s1677-5538.ibju.2018.05.03","article-title":"HPV vaccination is fundamental for reducing or erradicate penile cancer |Opinion: NO","volume":"44","author":"Ornellas","year":"2018","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.gendis.2025.101880_bib37","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1476-4598-10-140","article-title":"Papillomavirus E5: the smallest oncoprotein with many functions","volume":"10","author":"Venuti","year":"2011","journal-title":"Mol Cancer"},{"issue":"2","key":"10.1016\/j.gendis.2025.101880_bib38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00281-019-00773-0","article-title":"Epigenetic regulation of human papillomavirus transcription in the productive virus life cycle","volume":"42","author":"Burley","year":"2020","journal-title":"Semin Immunopathol"},{"issue":"5","key":"10.1016\/j.gendis.2025.101880_bib39","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3390\/pathogens14050464","article-title":"The epithelial immune response to human papillomavirus infection","volume":"14","author":"Roy-Biswas","year":"2025","journal-title":"Pathogens"},{"issue":"6","key":"10.1016\/j.gendis.2025.101880_bib40","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/pde.12113","article-title":"Human papillomavirus (HPV) genotyping of cutaneous warts in Greek children","volume":"30","author":"Giannaki","year":"2013","journal-title":"Pediatr Dermatol"},{"issue":"7 Suppl","key":"10.1016\/j.gendis.2025.101880_bib41","doi-asserted-by":"crossref","first-page":"29S","DOI":"10.1177\/0022034514527969","article-title":"Human papillomavirus (HPV)-associated oral cancers and treatment strategies","volume":"93","author":"Sathish","year":"2014","journal-title":"J Den Res"},{"issue":"24","key":"10.1016\/j.gendis.2025.101880_bib42","doi-asserted-by":"crossref","first-page":"12180","DOI":"10.1073\/pnas.89.24.12180","article-title":"Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic","volume":"89","author":"Kirnbauer","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gendis.2025.101880_bib43","first-page":"1","article-title":"Polychlorinated dibenzo-para-dioxins and Polychlorinated Dibenzofurans","volume":"69","year":"1997","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"10.1016\/j.gendis.2025.101880_bib44","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.vaccine.2006.05.115","article-title":"Chapter 1: HPV in the etiology of human cancer","volume":"24","author":"Mu\u00f1oz","year":"2006","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.gendis.2025.101880_bib45","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.vaccine.2005.09.002","article-title":"Immune responses to human papillomavirus","volume":"24","author":"Stanley","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.gendis.2025.101880_bib46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.bjc.6600688","article-title":"Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis","volume":"88","author":"Clifford","year":"2003","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.gendis.2025.101880_bib47","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","article-title":"Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis","volume":"7","author":"de Sanjos\u00e9","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.gendis.2025.101880_bib48","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","article-title":"Global burden of cancers attributable to infections in 2012: a synthetic analysis","volume":"4","author":"Plummer","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"11","key":"10.1016\/j.gendis.2025.101880_bib49","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","article-title":"Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group","volume":"87","author":"Bosch","year":"1995","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.gendis.2025.101880_bib50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.gendis.2025.101880_bib51","first-page":"1","article-title":"Human Papillomaviruses","volume":"64","year":"1995","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"issue":"2","key":"10.1016\/j.gendis.2025.101880_bib52","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1055-9965.EPI-04-0551","article-title":"Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review","volume":"14","author":"Kreimer","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"10.1016\/j.gendis.2025.101880_bib53","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/sj.bjc.6601272","article-title":"Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10000 women in Costa Rica","volume":"89","author":"Wang","year":"2003","journal-title":"Br J Cancer"},{"issue":"14","key":"10.1016\/j.gendis.2025.101880_bib54","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/jnci\/83.14.997","article-title":"Determinants of genital human papillomavirus infection in young women","volume":"83","author":"Ley","year":"1991","journal-title":"J Natl Cancer Inst"},{"issue":"15","key":"10.1016\/j.gendis.2025.101880_bib55","first-page":"4670","article-title":"Oral contraceptive use, human papillomavirus infection, and risk of early cytological abnormalities of the cervix","volume":"50","author":"Negrini","year":"1990","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.gendis.2025.101880_bib56","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/sj.bjc.6600971","article-title":"Human papillomavirus infection and use of oral contraceptives","volume":"88","author":"Green","year":"2003","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.gendis.2025.101880_bib57","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/infdis\/174.4.679","article-title":"Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women","volume":"174","author":"Burk","year":"1996","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.gendis.2025.101880_bib58","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1086\/380466","article-title":"Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population","volume":"189","author":"Tarkowski","year":"2004","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.gendis.2025.101880_bib59","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00007435-199309000-00009","article-title":"Determinants of genital human papillomavirus infection among cytologically normal women attending the university of New Mexico student health center","volume":"20","author":"Wheeler","year":"1993","journal-title":"Sex Transm Dis"},{"issue":"5","key":"10.1016\/j.gendis.2025.101880_bib60","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.bjc.6600194","article-title":"Prevalence and determinants of human papillomavirus genital infection in men","volume":"86","author":"Franceschi","year":"2002","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.gendis.2025.101880_bib61","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00007435-199320060-00004","article-title":"Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts","volume":"20","author":"Hippel\u00e4inen","year":"1993","journal-title":"Sex Transm Dis"},{"issue":"3","key":"10.1016\/j.gendis.2025.101880_bib62","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/sti.78.3.215","article-title":"Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic","volume":"78","author":"Svare","year":"2002","journal-title":"Sex Transm Infect"},{"issue":"3","key":"10.1016\/j.gendis.2025.101880_bib63","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/aje\/kwf180","article-title":"Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students","volume":"157","author":"Winer","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"Suppl 11","key":"10.1016\/j.gendis.2025.101880_bib64","doi-asserted-by":"crossref","first-page":"L16","DOI":"10.1016\/j.vaccine.2008.06.008","article-title":"Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean","volume":"26","author":"Almonte","year":"2008","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.gendis.2025.101880_bib65","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1186\/1750-9378-4-S1-S9","article-title":"Comparisons of high-risk cervical HPV infections in Caribbean and US populations","volume":"4","author":"Ragin","year":"2009","journal-title":"Infect Agents Cancer"},{"issue":"11","key":"10.1016\/j.gendis.2025.101880_bib66","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1158\/1055-9965.EPI-06-0556","article-title":"Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys","volume":"15","author":"Vaccarella","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.gendis.2025.101880_bib67","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1158\/1055-9965.EPI-06-0649","article-title":"Type-specific persistence of high-risk human papillomavirus infections in the New Independent States of the former Soviet Union cohort study","volume":"16","author":"Kulmala","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1016\/j.gendis.2025.101880_bib68","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/ijc.21493","article-title":"Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13, 541 women with carcinoma of the cervix and 23, 017 women without carcinoma of the cervix from 23 epidemiological studies","volume":"118","author":"Appleby","year":"2006","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.gendis.2025.101880_bib69","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00007435-199309000-00007","article-title":"Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon","volume":"20","author":"Bauer","year":"1993","journal-title":"Sex Transm Dis"},{"issue":"9","key":"10.1016\/j.gendis.2025.101880_bib70","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/aje\/kwh115","article-title":"Cigarette smoking, oncogenic human papillomavirus, Ki-67 antigen, and cervical intraepithelial neoplasia","volume":"159","author":"Harris","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"8","key":"10.1016\/j.gendis.2025.101880_bib71","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1086\/507432","article-title":"Prevalence of HPV infection among men: a systematic review of the literature","volume":"194","author":"Dunne","year":"2006","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.gendis.2025.101880_bib72","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/1055-9965.EPI-05-0577","article-title":"Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys","volume":"15","author":"Vaccarella","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.gendis.2025.101880_bib73","first-page":"101","article-title":"High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse)","volume":"10","author":"Kjaer","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.gendis.2025.101880_bib74","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00002030-199805000-00011","article-title":"High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men","volume":"12","author":"Palefsky","year":"1998","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.gendis.2025.101880_bib75","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/01.OLQ.0000079520.04451.59","article-title":"Human papillomavirus infection in men who have sex with men participating in a Dutch gay-cohort study","volume":"30","author":"van der Snoek","year":"2003","journal-title":"Sex Transm Dis"},{"issue":"12","key":"10.1016\/j.gendis.2025.101880_bib76","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1086\/425906","article-title":"Age-specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study","volume":"190","author":"Chin-Hong","year":"2004","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.gendis.2025.101880_bib77","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/aje\/kwg067","article-title":"Cancer in a population-based cohort of men and women in registered homosexual partnerships","volume":"157","author":"Frisch","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101880_bib78","first-page":"23","article-title":"Cancer statistics, 2002","volume":"52","author":"Jemal","year":"2002","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10.1016\/j.gendis.2025.101880_bib79","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/cncr.24161","article-title":"Predictive value of tumor thickness for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity: a meta-analysis of reported studies","volume":"115","author":"Huang","year":"2009","journal-title":"Cancer"},{"issue":"6046","key":"10.1016\/j.gendis.2025.101880_bib80","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.1208130","article-title":"The mutational landscape of head and neck squamous cell carcinoma","volume":"333","author":"Stransky","year":"2011","journal-title":"Science"},{"issue":"7536","key":"10.1016\/j.gendis.2025.101880_bib81","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature14129","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume":"517","author":"Lawrence","year":"2015","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.gendis.2025.101880_bib82","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1158\/1078-0432.CCR-13-3310","article-title":"Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas","volume":"21","author":"Seiwert","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.gendis.2025.101880_bib83","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s00595-013-0589-2","article-title":"The mutations of the EGFR and K-ras genes in resected stage I lung adenocarcinoma and their clinical significance","volume":"44","author":"Ohba","year":"2014","journal-title":"Surg Today"},{"issue":"1","key":"10.1016\/j.gendis.2025.101880_bib84","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/12615","article-title":"Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas","volume":"23","author":"Cappellen","year":"1999","journal-title":"Nat Genet"},{"issue":"16","key":"10.1016\/j.gendis.2025.101880_bib85","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1158\/0008-5472.CAN-12-3950","article-title":"Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinoma","volume":"73","author":"Liao","year":"2013","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.gendis.2025.101880_bib86","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ccr.2007.07.004","article-title":"Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma","volume":"12","author":"Annunziata","year":"2007","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.gendis.2025.101880_bib87","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/path.4239","article-title":"Constitutive activation of distinct NF-\u03baB signals in EBV-associated nasopharyngeal carcinoma","volume":"231","author":"Chung","year":"2013","journal-title":"J Pathol"},{"issue":"6","key":"10.1016\/j.gendis.2025.101880_bib88","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"9895","key":"10.1016\/j.gendis.2025.101880_bib89","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","article-title":"Human papillomavirus and cervical cancer","volume":"382","author":"Crosbie","year":"2013","journal-title":"Lancet"},{"issue":"7488","key":"10.1016\/j.gendis.2025.101880_bib90","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature12881","article-title":"Landscape of genomic alterations in cervical carcinomas","volume":"506","author":"Ojesina","year":"2014","journal-title":"Nature"},{"issue":"10 Suppl","key":"10.1016\/j.gendis.2025.101880_bib91","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/1097-0142(19951115)76:10+<1888::AID-CNCR2820761305>3.0.CO;2-H","article-title":"The epidemiology of cervical carcinogenesis","volume":"76","author":"Schiffman","year":"1995","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.gendis.2025.101880_bib92","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"36","key":"10.1016\/j.gendis.2025.101880_bib93","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1200\/JCO.2005.04.6136","article-title":"High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma","volume":"24","author":"Licitra","year":"2006","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.gendis.2025.101880_bib94","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/lary.20552","article-title":"Transoral laser microsurgery (TLM) \u00b1 adjuvant therapy for advanced stage oropharyngeal cancer","volume":"119","author":"Rich","year":"2009","journal-title":"Laryngoscope"},{"issue":"5","key":"10.1016\/j.gendis.2025.101880_bib95","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3201\/eid2005.131311","article-title":"Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States","volume":"20","author":"Steinau","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.gendis.2025.101880_bib96","first-page":"77","article-title":"New insights into human papillomavirus-associated head and neck squamous cell carcinoma","volume":"33","author":"Boscolo-Rizzo","year":"2013","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"4","key":"10.1016\/j.gendis.2025.101880_bib97","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.oraloncology.2014.10.005","article-title":"The role of surgery for HPV-associated head and neck cancer","volume":"51","author":"Mydlarz","year":"2015","journal-title":"Oral Oncol"},{"issue":"4","key":"10.1016\/j.gendis.2025.101880_bib98","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.otc.2013.04.009","article-title":"Impact of human papillomavirus on oropharyngeal cancer biology and response to therapy: implications for treatment","volume":"46","author":"Bonilla-Velez","year":"2013","journal-title":"Otolaryngol Clin North Am"},{"issue":"2","key":"10.1016\/j.gendis.2025.101880_bib99","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/MOO.0000000000000143","article-title":"Oropharyngeal cancer treatment: the role of transoral surgery","volume":"23","author":"Hinni","year":"2015","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.gendis.2025.101880_bib100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/hed.23850","article-title":"HPV-related oropharyngeal cancer: risk factors for treatment failure in patients managed with primary transoral robotic surgery","volume":"38","author":"Kaczmar","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.gendis.2025.101880_bib101","doi-asserted-by":"crossref","first-page":"154","DOI":"10.14694\/EdBook_AM.2014.34.154","article-title":"Surgery in the HPV era: the role of robotics and microsurgical techniques","author":"Ridge","year":"2014","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"8","key":"10.1016\/j.gendis.2025.101880_bib102","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1177\/014556131409300821","article-title":"Transoral robotic surgery and oropharyngeal cancer: a literature review","volume":"93","author":"O'Leary","year":"2014","journal-title":"Ear Nose Throat J"},{"issue":"2","key":"10.1016\/j.gendis.2025.101880_bib103","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0360-3016(95)02028-4","article-title":"Oropharyngeal carcinoma treated with radiotherapy: a 30-year experience","volume":"34","author":"Fein","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"21","key":"10.1016\/j.gendis.2025.101880_bib104","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1200\/JCO.2007.14.8841","article-title":"Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis","volume":"26","author":"Machtay","year":"2008","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.gendis.2025.101880_bib105","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/ijc.28847","article-title":"Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives","volume":"136","author":"Mirghani","year":"2015","journal-title":"Int J Cancer"},{"issue":"15","key":"10.1016\/j.gendis.2025.101880_bib106","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/j.ejca.2014.07.001","article-title":"De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of current clinical trials","volume":"50","author":"Masterson","year":"2014","journal-title":"Eur J Cancer"},{"issue":"10166","key":"10.1016\/j.gendis.2025.101880_bib107","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.gendis.2025.101880_bib108","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/cncr.29022","article-title":"A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy","volume":"121","author":"Setton","year":"2015","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.gendis.2025.101880_bib109","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.3390\/cancers6031793","article-title":"Human papillomavirus induced transformation in cervical and head and neck cancers","volume":"6","author":"Adams","year":"2014","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.gendis.2025.101880_bib110","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.oraloncology.2015.02.092","article-title":"The challenge of blocking a wider family members of EGFR against head and neck squamous cell carcinomas","volume":"51","author":"Martinez-Useros","year":"2015","journal-title":"Oral Oncol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101880_bib111","first-page":"58","article-title":"HPV and CSC in HNSCC cisplatin resistance","volume":"7","author":"Modur","year":"2015","journal-title":"Front Biosci (Elite Ed)"},{"key":"10.1016\/j.gendis.2025.101880_bib112","first-page":"362","article-title":"Carboplatin-pemetrexed in treatment of patients with recurrent\/metastatic cancers of the head and neck; superior outcomes in oropharyngeal primaries","volume":"4","author":"Malhotra","year":"2014","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.gendis.2025.101880_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132901","article-title":"Prognostic role of circulating tumor cells during induction chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer","volume":"10","author":"Inhestern","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.gendis.2025.101880_bib114","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/hed.24526","article-title":"Neoadjuvant chemotherapy and transoral surgery as a definitive treatment for oropharyngeal cancer: a feasible novel approach","volume":"38","author":"Sadeghi","year":"2016","journal-title":"Head Neck"},{"issue":"3","key":"10.1016\/j.gendis.2025.101880_bib115","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrclinonc.2015.209","article-title":"Combination cancer immunotherapies tailored to the tumour microenvironment","volume":"13","author":"Smyth","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"10.1016\/j.gendis.2025.101880_bib116","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1002\/ijc.28411","article-title":"The interplay between HPV and host immunity in head and neck squamous cell carcinoma","volume":"134","author":"Andersen","year":"2014","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.gendis.2025.101880_bib117","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ijc.28015","article-title":"Radiation-induced loss of cell surface CD47 enhances immune-mediated clearance of human papillomavirus-positive cancer","volume":"133","author":"Vermeer","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.gendis.2025.101880_bib118","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1471-2407-13-133","article-title":"Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR): study protocol for a randomized phase II trial","volume":"13","author":"Nichols","year":"2013","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.gendis.2025.101880_bib119","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.oraloncology.2013.10.003","article-title":"Combination antiangiogenic therapy and radiation in head and neck cancers","volume":"50","author":"Hsu","year":"2014","journal-title":"Oral Oncol"},{"issue":"4","key":"10.1016\/j.gendis.2025.101880_bib120","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hed.23319","article-title":"Intensity-modulated versus conventional radiation therapy for oropharyngeal carcinoma: long-term dysphagia and tumor control outcomes","volume":"36","author":"McBride","year":"2014","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.gendis.2025.101880_bib121","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/1533034615572638","article-title":"Decision trees predicting tumor shrinkage for head and neck cancer: implications for adaptive radiotherapy","volume":"15","author":"Surucu","year":"2016","journal-title":"Technol Cancer Res Treat"},{"issue":"12","key":"10.1016\/j.gendis.2025.101880_bib122","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/hed.23231","article-title":"Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation","volume":"35","author":"Broglie","year":"2013","journal-title":"Head Neck"},{"issue":"3","key":"10.1016\/j.gendis.2025.101880_bib123","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.radonc.2013.06.004","article-title":"Human papillomaviruses and cancer","volume":"108","author":"Haedicke","year":"2013","journal-title":"Radiother Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.gendis.2025.101880_bib124","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1007\/s12105-012-0364-5","article-title":"Primary chemotherapy and radiation as a treatment strategy for HPV-positive oropharyngeal cancer","volume":"6","author":"Lui","year":"2012","journal-title":"Head Neck Pathol"},{"issue":"7","key":"10.1016\/j.gendis.2025.101880_bib125","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1470-2045(09)70082-8","article-title":"Systemic effects of local radiotherapy","volume":"10","author":"Formenti","year":"2009","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.gendis.2025.101880_bib126","doi-asserted-by":"crossref","first-page":"403","DOI":"10.18632\/oncotarget.1719","article-title":"Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing","volume":"5","author":"Gameiro","year":"2014","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.gendis.2025.101880_bib127","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aag1266","article-title":"The intersection of radiotherapy and immunotherapy: mechanisms and clinical implications","volume":"1","author":"Spiotto","year":"2016","journal-title":"Sci Immunol"},{"key":"10.1016\/j.gendis.2025.101880_bib128","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev-med-051914-021907","article-title":"HPV-associated head and neck cancer: unique features of epidemiology and clinical management","volume":"67","author":"Maxwell","year":"2016","journal-title":"Annu Rev Med"},{"issue":"9","key":"10.1016\/j.gendis.2025.101880_bib129","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jnci\/92.9.709","article-title":"Evidence for a causal association between human papillomavirus and a subset of head and neck cancers","volume":"92","author":"Gillison","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.gendis.2025.101880_bib130","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s11912-014-0384-2","article-title":"Should patients with HPV-positive or negative tumors be treated differently?","volume":"16","author":"George","year":"2014","journal-title":"Curr Oncol Rep"},{"issue":"5","key":"10.1016\/j.gendis.2025.101880_bib131","first-page":"299","article-title":"HPV in oropharyngeal cancer: the basics to know in clinical practice","volume":"34","author":"Elrefaey","year":"2014","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"2","key":"10.1016\/j.gendis.2025.101880_bib132","doi-asserted-by":"crossref","DOI":"10.5041\/RMMJ.10144","article-title":"Transoral robotic surgery in the HPV era","volume":"5","author":"Duek","year":"2014","journal-title":"Rambam Maimonides Med J"},{"key":"10.1016\/j.gendis.2025.101880_bib133","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/696028","article-title":"Biological basis for increased sensitivity to radiation therapy in HPV-positive head and neck cancers","volume":"2014","author":"Bol","year":"2014","journal-title":"BioMed Res Int"},{"issue":"3","key":"10.1016\/j.gendis.2025.101880_bib134","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.otpol.2013.01.003","article-title":"Recommendations for the diagnosis of human papilloma virus (HPV) high and low risk in the prevention and treatment of diseases of the oral cavity, pharynx and larynx. Guide of experts PTORL and KIDL","volume":"67","author":"Wierzbicka","year":"2013","journal-title":"Otolaryngol Pol"},{"issue":"12","key":"10.1016\/j.gendis.2025.101880_bib135","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/cncr.29323","article-title":"Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer","volume":"121","author":"Guo","year":"2015","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.gendis.2025.101880_bib136","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3390\/cancers6031705","article-title":"Human papillomavirus in head and neck cancer","volume":"6","author":"Garbuglia","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.gendis.2025.101880_bib137","doi-asserted-by":"crossref","first-page":"610","DOI":"10.5604\/17322693.1058431","article-title":"Human papillomavirus and its influence on head and neck cancer predisposition","volume":"67","author":"Nelke","year":"2013","journal-title":"Postepy Hig Med Dosw (Online)"},{"issue":"4","key":"10.1016\/j.gendis.2025.101880_bib138","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.ijrobp.2013.08.029","article-title":"Review of the clinical and biologic aspects of human papillomavirus-positive squamous cell carcinomas of the head and neck","volume":"88","author":"Blitzer","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.gendis.2025.101880_bib139","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1158\/0008-5472.CAN-14-3124","article-title":"Novel insights into head and neck cancer using next-generation \"omic\" technologies","volume":"75","author":"Sepiashvili","year":"2015","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.gendis.2025.101880_bib140","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.ajpath.2014.01.028","article-title":"Molecular heterogeneity of head and neck squamous cell carcinoma defined by next-generation sequencing","volume":"184","author":"Zhang","year":"2014","journal-title":"Am J Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.gendis.2025.101880_bib141","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1007\/s12105-012-0362-7","article-title":"The role for surgical management of HPV-related oropharyngeal carcinoma","volume":"6","author":"Genden","year":"2012","journal-title":"Head Neck Pathol"},{"issue":"4","key":"10.1016\/j.gendis.2025.101880_bib142","doi-asserted-by":"crossref","first-page":"781","DOI":"10.5306\/wjco.v5.i4.781","article-title":"Clinical and scientific impact of human papillomavirus on head and neck cancer","volume":"5","author":"Friedman","year":"2014","journal-title":"World J Clin Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.gendis.2025.101880_bib143","first-page":"E2190","article-title":"Decision management in transoral robotic surgery: indications, individual patient selection, and role in the multidisciplinary treatment for head and neck cancer from a European perspective","volume":"38","author":"L\u00f6rincz","year":"2016","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.gendis.2025.101880_bib144","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4103\/0973-1482.151445","article-title":"HPV positive oropharyngeal cancer and treatment deintensification: how pertinent is it?","volume":"11","author":"Laskar","year":"2015","journal-title":"J Cancer Res Ther"},{"issue":"5","key":"10.1016\/j.gendis.2025.101880_bib145","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41591-020-0840-5","article-title":"Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer","volume":"26","author":"Lu","year":"2020","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.gendis.2025.101880_bib146","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.canlet.2010.12.002","article-title":"HPV prophylactic vaccination: the first years and what to expect from now","volume":"305","author":"Villa","year":"2011","journal-title":"Cancer Lett"},{"issue":"32","key":"10.1016\/j.gendis.2025.101880_bib147","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.gendis.2025.101880_bib148","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.otc.2012.04.005","article-title":"Biology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers","volume":"45","author":"Best","year":"2012","journal-title":"Otolaryngol Clin North Am"},{"issue":"5","key":"10.1016\/j.gendis.2025.101880_bib149","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.oraloncology.2015.01.011","article-title":"Sexual behavior, HPV knowledge, and association with head and neck cancer among a high-risk group","volume":"51","author":"Osazuwa-Peters","year":"2015","journal-title":"Oral Oncol"},{"issue":"4","key":"10.1016\/j.gendis.2025.101880_bib150","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3122\/jabfm.2015.04.140301","article-title":"The growing epidemic of HPV-positive oropharyngeal carcinoma: a clinical review for primary care providers","volume":"28","author":"Moore","year":"2015","journal-title":"J Am Board Fam Med"},{"issue":"1","key":"10.1016\/j.gendis.2025.101880_bib151","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1586\/14737140.2015.957189","article-title":"The role of sexual behavior in head and neck cancer: implications for prevention and therapy","volume":"15","author":"Rettig","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"issue":"6","key":"10.1016\/j.gendis.2025.101880_bib152","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.oraloncology.2013.06.007","article-title":"Prospects for prevention of HPV-driven oropharynx cancer","volume":"50","author":"Kreimer","year":"2014","journal-title":"Oral Oncol"},{"key":"10.1016\/j.gendis.2025.101880_bib153","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pvr.2017.12.006","article-title":"Therapeutic vaccines for high-risk HPV-associated diseases","volume":"5","author":"Chabeda","year":"2018","journal-title":"Papillomavirus Res"},{"issue":"12","key":"10.1016\/j.gendis.2025.101880_bib154","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S1470-2045(09)70358-4","article-title":"A review of human carcinogens: part F: chemical agents and related occupations","volume":"10","author":"Baan","year":"2009","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.gendis.2025.101880_bib155","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1007\/s12033-021-00374-z","article-title":"In silico design and immunological studies of two novel multiepitope DNA-based vaccine candidates against high-risk human papillomaviruses","volume":"63","author":"Kayyal","year":"2021","journal-title":"Mol Biotechnol"},{"issue":"4","key":"10.1016\/j.gendis.2025.101880_bib156","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1517\/14728214.2012.744393","article-title":"Emerging human papillomavirus vaccines","volume":"17","author":"Ma","year":"2012","journal-title":"Expert Opin Emerg Drugs"},{"issue":"Suppl 1","key":"10.1016\/j.gendis.2025.101880_bib157","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1007\/s12105-012-0361-8","article-title":"Future directions in research, treatment and prevention of HPV-related squamous cell carcinoma of the head and neck","volume":"6","author":"Psyrri","year":"2012","journal-title":"Head Neck Pathol"},{"issue":"Suppl 5","key":"10.1016\/j.gendis.2025.101880_bib158","doi-asserted-by":"crossref","first-page":"F71","DOI":"10.1016\/j.vaccine.2012.05.091","article-title":"Therapy of human papillomavirus-related disease","volume":"30","author":"Stern","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.gendis.2025.101880_bib159","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.mjafi.2015.02.006","article-title":"HPV vaccine: current status and future directions","volume":"71","author":"Kumar","year":"2015","journal-title":"Med J Armed Forces India"},{"issue":"2","key":"10.1016\/j.gendis.2025.101880_bib160","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ijc.27676","article-title":"Successful therapeutic vaccination with integrase defective lentiviral vector expressing nononcogenic human papillomavirus E7 protein","volume":"132","author":"Grasso","year":"2013","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.gendis.2025.101880_bib161","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/154411130301400505","article-title":"Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma","volume":"14","author":"Devaraj","year":"2003","journal-title":"Crit Rev Oral Biol Med"},{"issue":"9","key":"10.1016\/j.gendis.2025.101880_bib162","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1586\/erv.09.76","article-title":"Therapeutic HPV DNA vaccines","volume":"8","author":"Monie","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"10.1016\/j.gendis.2025.101880_bib163","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0929-6646(10)60017-4","article-title":"Perspectives for preventive and therapeutic HPV vaccines","volume":"109","author":"Lin","year":"2010","journal-title":"J Formos Med Assoc"},{"issue":"10","key":"10.1016\/j.gendis.2025.101880_bib164","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S1470-2045(09)70227-X","article-title":"Development of therapeutic HPV vaccines","volume":"10","author":"Trimble","year":"2009","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.gendis.2025.101880_bib165","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ijc.20244","article-title":"Against which human papillomavirus types shall we vaccinate and screen? The international perspective","volume":"111","author":"Mu\u00f1oz","year":"2004","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.gendis.2025.101880_bib166","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jnci\/djq562","article-title":"Human papillomavirus testing in the prevention of cervical cancer","volume":"103","author":"Schiffman","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"16","key":"10.1016\/j.gendis.2025.101880_bib167","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.vaccine.2021.01.060","article-title":"Systematic literature review of neutralizing antibody immune responses to non-vaccine targeted high-risk HPV types induced by the bivalent and the quadrivalent vaccines","volume":"39","author":"Stanley","year":"2021","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.gendis.2025.101880_bib168","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1470-2045(11)70286-8","article-title":"Overall efficacy of HPV-16\/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"Lehtinen","year":"2012","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.gendis.2025.101880_bib169","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/597307","article-title":"The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16\u201326 years","volume":"199","author":"Brown","year":"2009","journal-title":"J Infect Dis"},{"issue":"19","key":"10.1016\/j.gendis.2025.101880_bib170","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/jnci\/djq326","article-title":"Impact of human papillomavirus (HPV)-6\/11\/16\/18 vaccine on all HPV-associated genital diseases in young women","volume":"102","author":"Brewer","year":"2010","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.gendis.2025.101880_bib171","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1158\/1940-6207.CAPR-11-0284","article-title":"Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal \"pap-test equivalent\" in high-risk populations","volume":"4","author":"Fakhry","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"issue":"Suppl 8","key":"10.1016\/j.gendis.2025.101880_bib172","doi-asserted-by":"crossref","first-page":"S759","DOI":"10.1093\/cid\/civ771","article-title":"Centers for disease control and prevention sexually transmitted diseases treatment guidelines","volume":"61","author":"Workowski","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.gendis.2025.101880_bib173","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/AOG.0b013e3182883a34","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"121","author":"Massad","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.gendis.2025.101880_bib174","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/DCR.0b013e318227833e","article-title":"Long-term follow-up of infrared coagulator ablation of anal high-grade dysplasia in men who have sex with men","volume":"54","author":"Goldstone","year":"2011","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"10.1016\/j.gendis.2025.101880_bib175","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/QAI.0b013e3182437469","article-title":"Electrocautery ablation of high-grade anal squamous intraepithelial lesions in HIV-negative and HIV-positive men who have sex with men","volume":"59","author":"Marks","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"10.1016\/j.gendis.2025.101880_bib176","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1258\/ijsa.2007.007290","article-title":"Treatment of anal human papillomavirus-associated disease: a long term outcome study","volume":"19","author":"Nathan","year":"2008","journal-title":"Int J STD AIDS"},{"issue":"4","key":"10.1016\/j.gendis.2025.101880_bib177","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.idc.2013.09.001","article-title":"HPV and HPV-associated diseases","volume":"27","author":"Dunne","year":"2013","journal-title":"Infect Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.gendis.2025.101880_bib178","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/gyno.1993.1271","article-title":"Cervical conization as definitive therapy for early invasive squamous carcinoma of the cervix","volume":"51","author":"Morris","year":"1993","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.gendis.2025.101880_bib179","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/gyno.2002.6650","article-title":"Delivery outcomes following loop electrosurgical excision procedure for microinvasive (FIGO stage IA1) cervical cancer","volume":"86","author":"Paraskevaidis","year":"2002","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.gendis.2025.101880_bib180","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1515\/hsz-2017-0105","article-title":"Human papillomavirus first and second generation vaccines \u2013 current status and future directions","volume":"398","author":"Pouyanfard","year":"2017","journal-title":"Biol Chem"},{"issue":"11","key":"10.1016\/j.gendis.2025.101880_bib181","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048426","article-title":"Potential benefits of second-generation human papillomavirus vaccines","volume":"7","author":"Kiatpongsan","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.gendis.2025.101880_bib182","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jnci\/93.4.284","article-title":"Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine","volume":"93","author":"Harro","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.gendis.2025.101880_bib183","series-title":"Paper Presented at: 18Th International Papillomavirus Conference","article-title":"A randomized, doubleblind, placebo-controlled trial of the immunogenicity and reactogenicity of a novel HPV16 vaccine: preliminary results","author":"Poland","year":"2000"},{"issue":"RR-05","key":"10.1016\/j.gendis.2025.101880_bib184","first-page":"1","article-title":"Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"63","author":"Markowitz","year":"2014","journal-title":"MMWR Recomm Rep"},{"issue":"20","key":"10.1016\/j.gendis.2025.101880_bib185","first-page":"626","article-title":"FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP)","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"50","key":"10.1016\/j.gendis.2025.101880_bib186","first-page":"1705","article-title":"Recommendations on the use of quadrivalent human papillomavirus vaccine in males: Advisory Committee on Immunization Practices (ACIP), 2011","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9686","key":"10.1016\/j.gendis.2025.101880_bib187","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.gendis.2025.101880_bib188","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1158\/1940-6207.CAPR-09-0031","article-title":"A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (types 6\/11\/16\/18) vaccine against high-grade cervical and external genital lesions","volume":"2","author":"Kjaer","year":"2009","journal-title":"Cancer Prev Res (Phila)"},{"issue":"9574","key":"10.1016\/j.gendis.2025.101880_bib189","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(07)60777-6","article-title":"Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials","volume":"369","author":"Joura","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.gendis.2025.101880_bib190","article-title":"Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial","volume":"341","author":"Dillner","year":"2010","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.gendis.2025.101880_bib191","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4161\/hv.18865","article-title":"Sustained immunogenicity and efficacy of the HPV-16\/18 AS04-adjuvanted vaccine: up to 8.4 years of follow-up","volume":"8","author":"Roteli-Martins","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.gendis.2025.101880_bib192","first-page":"591","article-title":"Human papillomavirus vaccination coverage among adolescent girls, 2007\u20132012, and postlicensure vaccine safety monitoring, 2006\u20132013: united States","volume":"62","author":"Stokley","year":"2013","journal-title":"Morb Mortal Week Rep"},{"issue":"7","key":"10.1016\/j.gendis.2025.101880_bib193","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.298.7.743","article-title":"Effect of human papillomavirus 16\/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial","volume":"298","author":"Hildesheim","year":"2007","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.gendis.2025.101880_bib194","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa053284","article-title":"Condom use and the risk of genital human papillomavirus infection in young women","volume":"354","author":"Winer","year":"2006","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.gendis.2025.101880_bib195","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1111\/1471-0528.16758","article-title":"Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study","volume":"128","author":"Luckett","year":"2021","journal-title":"BJOG"},{"key":"10.1016\/j.gendis.2025.101880_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2021.12.203","article-title":"Detection of human papillomavirus and co-infection with other sexually transmitted pathogens in northern Peru","volume":"116","author":"Champin","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.gendis.2025.101880_bib197","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.10793","article-title":"Detection of sexually transmitted pathogens and co-infection with human papillomavirus in women residing in rural Eastern Cape, South Africa","volume":"9","author":"Taku","year":"2021","journal-title":"PeerJ"},{"key":"10.1016\/j.gendis.2025.101880_bib198","article-title":"Co-infection of human papillomavirus and other sexually transmitted bacteria in cervical cancer patients in the Philippines","volume":"40","author":"Tantengco","year":"2022","journal-title":"Gynecol Oncol Rep"},{"issue":"4","key":"10.1016\/j.gendis.2025.101880_bib199","first-page":"1313","article-title":"Impact of combined mycoplasmataceae and HPV co-infection on females with cervical intraepithelial neoplasia and carcinoma","volume":"26","author":"Adamopoulou","year":"2021","journal-title":"J BUON"},{"issue":"11","key":"10.1016\/j.gendis.2025.101880_bib200","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.31557\/APJCP.2022.23.11.3931","article-title":"Prevalence of human papillomavirus and co-infection with Epstein-Barr virus in oral and oropharyngeal squamous cell carcinomas","volume":"23","author":"Makvandi","year":"2022","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["Genes &amp; Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225003691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304225003691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T06:42:51Z","timestamp":1773988971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304225003691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":200,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2352304225003691"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101880","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in human papillomavirus vaccines and therapeutic strategies: Combating cervical and non-cervical cancers","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2025.101880","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101880"}}